DBV Technologies (DBVT) Other Accumulated Expenses (2019 - 2026)
DBV Technologies (DBVT) reported Other Accumulated Expenses of $10.8 million for Q1 2026, up 98.27% year-over-year from $5.4 million in Q1 2025, and down 31.65% quarter-over-quarter from $15.8 million in Q4 2025.
DBV Technologies (DBVT) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 8 years of Other Accumulated Expenses data on file, last reported at $10.8 million in Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $10.8 million, up 98.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.8 million (up 98.27% YoY), and the FY2025 annual result was $15.8 million, up 89.72% from the prior year.
- Other Accumulated Expenses eased to $10.8 million in Q1 2026 per DBVT's latest filing, from $15.8 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $15.8 million in Q4 2025 and troughed at $5.0 million in Q1 2024.
- A 5-year average of $8.4 million and a median of $8.4 million in 2025 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2026: Other Accumulated Expenses sank 34.9% in 2022, then soared 98.27% in 2026.
- A 5-year view of Other Accumulated Expenses shows it stood at $9.2 million in 2022, then decreased by 3.0% to $8.9 million in 2023, then decreased by 6.78% to $8.3 million in 2024, then jumped by 89.72% to $15.8 million in 2025, then sank by 31.65% to $10.8 million in 2026.
- Business Quant data shows DBVT's Other Accumulated Expenses at $10.8 million in Q1 2026, $15.8 million in Q4 2025, and $8.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.80 Mn |
| Dec 31, 2025 | 15.80 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Jun 30, 2025 | 7.52 Mn |
| Mar 31, 2025 | 5.45 Mn |
| Dec 31, 2024 | 8.33 Mn |
| Sep 30, 2024 | 7.79 Mn |
| Jun 30, 2024 | 6.16 Mn |
| Mar 31, 2024 | 5.02 Mn |
| Dec 31, 2023 | 8.93 Mn |
| Sep 30, 2023 | 8.67 Mn |
| Jun 30, 2023 | 7.26 Mn |
| Mar 31, 2023 | 6.78 Mn |
| Dec 31, 2022 | 9.21 Mn |
| Sep 30, 2022 | 8.62 Mn |
| Jun 30, 2022 | 8.78 Mn |
| Mar 31, 2022 | 8.72 Mn |
| Dec 31, 2021 | 12.36 Mn |
| Sep 30, 2021 | 12.66 Mn |
| Jun 30, 2021 | 12.67 Mn |